Dragan Ilic1, Kerry Murphy, Sally Green. 1. PhD, Associate Professor, Monash University, Department of Epidemiology & Preventive Medicine, Melbourne, Victoria.
Abstract
BACKGROUND: Men seek advice from their general practitioner (GP) on the merits of screening for prostate cancer. This study aimed to examine how the knowledge and clinical experience of GPs influenced their position on prostate cancer screening. METHODS: A total of 13 focus groups were set up with 77 GPs. Focus group discussions were audio-taped and transcribed verbatim. Transcripts were analysed by two investigators via thematic analysis. RESULTS: GPs were evenly divided between those who proactively screen men for prostate cancer and those who do so only at the patient's request. GPs had limited knowledge of recently published evidence from trials on prostate cancer screening. DISCUSSION: Effective methods of increasing GP knowledge about evidence-based recommendations and potentially changing clinical behaviour are required in order to promote evidence-based decision-making by GPs and their patients.
BACKGROUND:Men seek advice from their general practitioner (GP) on the merits of screening for prostate cancer. This study aimed to examine how the knowledge and clinical experience of GPs influenced their position on prostate cancer screening. METHODS: A total of 13 focus groups were set up with 77 GPs. Focus group discussions were audio-taped and transcribed verbatim. Transcripts were analysed by two investigators via thematic analysis. RESULTS: GPs were evenly divided between those who proactively screen men for prostate cancer and those who do so only at the patient's request. GPs had limited knowledge of recently published evidence from trials on prostate cancer screening. DISCUSSION: Effective methods of increasing GP knowledge about evidence-based recommendations and potentially changing clinical behaviour are required in order to promote evidence-based decision-making by GPs and their patients.
Authors: Minh-Phuong Huynh-Le; Chun Chieh Fan; Roshan Karunamuni; Eleanor I Walsh; Emma L Turner; J Athene Lane; Richard M Martin; David E Neal; Jenny L Donovan; Freddie C Hamdy; J Kellogg Parsons; Rosalind A Eeles; Douglas F Easton; Zsofia Kote-Jarai; Ali Amin Al Olama; Sara Benlloch Garcia; Kenneth Muir; Henrik Grönberg; Fredrik Wiklund; Markus Aly; Johanna Schleutker; Csilla Sipeky; Teuvo Lj Tammela; Børge Grønne Nordestgaard; Timothy J Key; Ruth C Travis; Paul D P Pharoah; Nora Pashayan; Kay-Tee Khaw; Stephen N Thibodeau; Shannon K McDonnell; Daniel J Schaid; Christiane Maier; Walther Vogel; Manuel Luedeke; Kathleen Herkommer; Adam S Kibel; Cezary Cybulski; Dominika Wokolorczyk; Wojciech Kluzniak; Lisa A Cannon-Albright; Hermann Brenner; Ben Schöttker; Bernd Holleczek; Jong Y Park; Thomas A Sellers; Hui-Yi Lin; Chavdar Kroumov Slavov; Radka P Kaneva; Vanio I Mitev; Jyotsna Batra; Judith A Clements; Amanda B Spurdle; Manuel R Teixeira; Paula Paulo; Sofia Maia; Hardev Pandha; Agnieszka Michael; Ian G Mills; Ole A Andreassen; Anders M Dale; Tyler M Seibert Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-06-24 Impact factor: 4.254